Академический Документы
Профессиональный Документы
Культура Документы
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
566
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48. Gould, S. J. & Lewontin, R. C. The Spandrels of SanMarco and the Panglossian paradigm a critique of the
adaptationist program. Proc. Royal Soc. London B 205,
581598 (1979).
49. Iltis, H. H. From teosinte to maize: the catastrophic sexual
transmutation. Science 222, 886894 (1983).
50. Iltis, H. H. Homeotic sexual translocations and the
origin of maize (Zea mays, Poaceae): a new look at an
old problem. Econ. Bot. 54, 742 (2000).
51. Lauter, N. & Doebley, J. Genetic variation for
phenotypically invariant traits detected in teosinte:
implications for the evolution of novel forms. Genetics
160, 333342 (2002).
52. Gibson, G. Developmental evolution: going beyond the
just so. Curr. Biol. 9, 942945 (1999).
Acknowledgements
I would like to thank E. Meyerowitz, in whose laboratory this
work began, J. Trager of Huntington Gardens, San Marino,
California, and L. Song of the University of California,
Fullerton, for Welwitschia materials, and two anonymous
reviewers. This work is supported by a National Science
Foundation grant.
Online Links
DATABASES
The following terms in this article are linked online to:
MaizeGDB: http://www.maizegdb.org
rolled leaf 1
TAIR: http://www.arabidopsis.org
INO | LFY | STM
FURTHER INFORMATION
Floral Genome Project:
http://fgp.bio.psu.edu/fgp/index.html
Access to this interactive links box is free online.
TIMELINE
www.nature.com/reviews/genetics
PERSPECTIVES
Z-DNA segment
(one turn)
= 3
= 1
PERSPECTIVES
1972
1979
1981
1982
Z-DNA is found
to be stabilized
by negative
supercoiling.
P3
P1
275
336
Z1
Z2
245
Z3
Exon 1
Exon 2
Exon 3
568
1983
1987
1989
1991
1992
1995
The Z-DNA-binding
domain from the
ADAR1 editing enzyme
is isolated, and a
Z-DNA-specific
restriction endonuclease
is constructed.
1997
It is shown that
the Z-DNAbinding domain
of ADAR1 binds
Z-RNA as well
as Z-DNA.
1999
2000
www.nature.com/reviews/genetics
PERSPECTIVES
prevalence of sequences that favour Z-DNA
formation near transcription sites, it is possible
that this mechanism is widespread 22.
Proteins that bind Z-DNA
A yeast one-hybrid system shows
that Z-DNA-binding proteins can
act as potent effectors of gene
expression in vivo.
2001
2002
Nucleosome remodelling of
the human CSF1 gene
shown to produce Z-DNA in
the promoter region that is
necessary for transcription.
2003
of a Z-DNA-binding nuclear-RNA-editing
enzyme32 called double-stranded RNA
adenosine deaminase (ADAR1).
ADAR1 acts on double-stranded segments
that are formed in pre-mRNA, binding to the
duplex and selectively deaminating adenosine
to yield inosine. Ribosomes interpret inosine
as guanine, so it can alter the amino-acid
sequence of a DNA-encoded protein. A typical substrate of this enzyme is an RNA duplex
in which an exon is paired with a region of an
intron. The deaminase edits several premRNAs, including a glutamate receptor that
is expressed in the central nervous system
(CNS)33. The receptor is an ion channel, and
a glutamine residue near the centre of the
channel is changed through editing to arginine; its positive charge restricts the entry of
calcium ions, a change that is essential for
CNS function. Another substrate is the serotonin receptor33. In all of these cases, the
functional properties of the edited protein
(with the amino-acid alteration) are
detectably different from those of the
unedited protein. The editing enzyme is
found in all metazoa and acts to increase the
functional diversity of proteins that are
transcribed from a given locus.
PERSPECTIVES
A Z-DNA-binding domain
Box 2 | Z-RNA
The discovery of the structure of left-handed Z-DNA naturally led to the question of whether
RNA could also form this conformation. In 1982, chemically modified oligoribonucleotides
indicated that this was a possibility56, and further nuclear magnetic resonance, circular dichroism
and absorption spectroscopy studies strongly indicated that Z-RNA could be formed in highionic-strength solutions57,58. More detailed structural information was obtained from X-ray
crystallographic studies with chimeric hexamers that were made of alternating CG residues in
which the two central CG residues were ribonucleotides, whereas the flanking pair of nucleotides
were deoxyribonucleotides. These and other structural studies showed that the conformation of
Z-RNA was similar to that of Z-DNA59,60. Z-RNA was also found to be immunogenic and,
although Z-RNA specific antibodies could be isolated61, some antibodies recognized both Z-RNA
and Z-DNA. Staining experiments with Z-RNA-specific antibodies showed that the antibody
bound to fixed protozoan cells that were visualized by immunofluorescence microscopy. The
antibodies were mostly found in the cytoplasm, which indicated that some cytoplasmic sequences
in fixed cells existed as Z-RNA62. Cytoplasmic microinjection of anti-Z-RNA antibodies was
found to inhibit cell multiplication63.
The experiments on Z-RNA were mostly carried out in the late 1980s, and since 1990 there
have been no further publications. However, a possible physiological role for Z-RNA was
suggested recently by Brown, and Lowenhaupt et al., who found that the Z-DNA-binding
domain of the editing enzyme double-stranded RNA adenosine deaminase (ADAR1) could
bind to Z-RNA and Z-DNA64 with similar affinity. It had been known for some time that certain
RNA viruses that replicate in the cytoplasm undergo considerable changes in sequence, which
were probably the consequence of hyper-editing by ADAR1. Sequence analysis of the virus
found in measles encephalitis showed that the RNA undergoes many edits: adenines are
replaced by guanines, and uracils by cytosines. So, this virus has been extensively hyper-edited
by the editing enzyme64. Full length ADAR1 that contains the
Z-DNA-binding domain is upregulated by the interferon response of the cell, which is triggered
by the measles virus. Furthermore, ADAR1 accumulates in the cytoplasm in which the measles
virus replicates. So, it is possible that the ZADAR1 binds to negatively torsionally strained
double-stranded RNA, which might form during viral replication, targeting the editing enzyme
to this site. The Z-DNA/Z-RNA-binding domain might have a role in the attempts of cells to
inactivate the invading virus. More experimental data are needed to test this hypothesis.
570
www.nature.com/reviews/genetics
PERSPECTIVES
vaccinia virus, it might also be active in
humans. This molecule could be developed
to eliminate the harmful side-effects of vaccination. More importantly, the E3L protein
of the closely related variola virus, which is
the agent of smallpox, is almost identical to
the vaccinia E3L45. So, small molecule drugs
that bind to E3L might make it possible to
develop a therapy for smallpox.
This is the first example in which a
Z-DNA-binding protein has been found to be
involved in viral pathogenesis. If other viruses
use a similar mechanism to downregulate the
host response, then these proteins might be
potential targets for anti-viral drugs.
100
80
% Survival
60
WT (ZE3L)
40
E3L (1 83)
Z DLM1
20
Z ADAR1
Conclusions
0
0
10
12
Days post-infection
Figure 4 | The lethality of mice following intracerebral inoculation of 100 viral plaque-forming units
of vaccinia virus constructs45. No lethality is associated with the deletion of the 83 N-terminal residues of
the E3L protein (183). However, the wild-type (WT) virus and the two chimeric viruses in which the wildtype E3L N-terminal domain has been substituted by either ZDLM1 or ZADAR1 are all equally pathogenic. The
wild type and the two chimeric E3L molecules have residues in common, which are important in binding
Z-DNA in the two co-crystal structures that have been solved. Reproduced with permission from REF. 45.
To investigate the pathogenicity of the vaccinia virus in the mouse, and its relationship
to the possible Z-DNA-binding activities of
E3L, a collaboration was set up between the
Rich laboratory and the Jacobs laboratory.
Chimeric viruses were created in which the
N-terminal domain of vaccinia E3L (ZE3L)
was removed. ZE3L has sequence similarities
to ZADAR1 and ZDLM1. Two chimeric viruses
were created in which the two known
Z-DNA-binding domains were substituted
for Z E3L. In carrying out these domain swaps,
a little more than a dozen amino acids in the
domain remained unchanged; these were the
residues that were known to bind Z-DNA in
the co-crystals. However, more than 50 other
residues were changed. The chimeric viruses
were as pathogenic as the wild type45; however, when the N-terminal residues of vaccinia E3L were deleted, the mice survived
(FIG. 4). Other experiments were carried out
in which mutations were introduced into
both chimeric and wild-type viruses; if
Z-DNA binding was weakened by these
mutations, viral pathogenicity was reduced45.
It was postulated that the ZE3L domain in the
nucleus of the infected cell might bind to the
Glossary
ADAR1
CIRCULAR DICHROISM
POLYTENE CHROMOSOME
PERSPECTIVES
Alexander Rich is at the Department of Biology,
Massachusetts Institute of Technology,
77 Massachusetts Avenue, Room 68-233,
Cambridge, Massachusetts 02139, USA.
Shuguang Zhang is at the
Center for Biomedical Engineering,
Massachusetts Institute of Technology,
77 Massachusetts Avenue, Room NE47-379,
Cambridge, Massachusetts 02139, USA.
Correspondence to S.Z.
e-mail: shuguang@mit.edu
doi:10.1038/nrg1115
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
572
46. Zhang, S., Lockshin, C., Herbert, A., Winter, E. & Rich, A.
Zuotin, a putative Z-DNA binding protein in
Saccharomyces cerevisiae. EMBO J. 11, 37873796
(1992).
47. Zhang, S., Holmes, T., Lockshin, C. & Rich, A.
Spontaneous assembly of a self-complementary
oligopeptide to form a stable macroscopic
membrane. Proc. Natl Acad. Sci. USA 90, 33343338
(1993).
48. Zhang, S. et al. Self-complementary oligopeptide
matrices support mammalian cell attachment.
Biomaterials 16, 13851393 (1995).
49. Holmes, T., Delacalle, S., Su, X., Rich, A. & Zhang, S.
Extensive neurite outgrowth and active neuronal
synapses on peptide scaffolds. Proc. Natl Acad. Sci.
USA 97, 67286733 (2000).
50. Kisiday, J. et al. Self-assembling peptide hydrogel
fosters chondrocyte extracellular matrix production and
cell division: implications for cartilage tissue repair. Proc.
Natl Acad. Sci. USA 99, 999610001 (2002).
51. Zhang, S. & Rich, A. Direct conversion of an oligopeptide
from a -sheet to an -helix: a model for amyloid
formation. Proc. Natl Acad. Sci. USA 94, 2328 (1997).
52. Zhang, S. et al. Biological surface engineering: a simple
system for cell pattern formation. Biomaterials 20,
12131220 (1999).
53. Vauthey, S., Santoso, S., Gong, H., Watson, N. &
Zhang, S. Molecular self-assembly of surfactant-like
peptides to form nanotubes and nanovesicles. Proc. Natl
Acad. Sci. USA 99, 53555360 (2002).
54. von Maltzahn, G., Vauthey, S., Santoso, S. & Zhang, S.
Positively charged surfactant-like peptides selfassemble into nanostructures. Langmuir 19,
43324337 (2003).
55. Zhang, S. Building from bottom-up. Materials Today 6,
2027 (2003).
56. Uesugi, W., Shida, T. & Ikehara, M. Synthesis and
properties of CpG analogues containing an
8-bromoguanosine residue. Evidence for Z-RNA duplex
formation. Biochemistry 21, 34003408 (1982).
57. Hall, K., Cruz, P., Tinoko, I., Jovin, T. M. &
van de Sande, J. H. Z-RNA a left-handed RNA
double helix. Nature 311, 584586 (1984).
58. Davis, P. W., Hall, K., Cruz, P., Tinoco, I. & Neilson, T. The
tetraribonucleotide rCpGpCpG forms a left-handed
Z-RNA double helix. Nucleic Acids Res. 14, 12791291
(1986).
59. Teng, M. K., Liaw, Y. C., van der Marel, G. A., van Boom,
J. H. & Wang, A.-H. Effects of the O2 hydroxyl group on
Z-DNA conformation: structure of Z-RNA and (araC)[Z-DNA]. Biochemistry 28, 4923 4928 (1989).
60. Davis, P. W., Adamiak, R. W. & Tinoco, I. Z-RNA: the
solution NMR structure of r(CGCGCG). Biopolymers 29,
109122 (1990).
61. Hardin, C. C., Zarling, D. A., Wolk, S. K., Ross, W. S. &
Tincoc, I. Characterization of anti-Z-RNA polyclonal
antibodies: epitope properties and recognition of Z-DNA.
Biochemistry 27, 41694177 (1988).
62. Zarling, D. A., Calhoun, C. J., Hardin, C. C. & Zarling, A. H.
Cytoplasmic Z-RNA. Proc. Natl Acad. Sci. USA 84,
61176121 (1987).
63. Zarling, D. A., Calhoun, C. J., Feuerstein, B. G. &
Sena, E. P. Cytoplasmic microinjection of
immunoglobulin Gs recognizing RNA helices inhibits
human cell growth.
J. Mol. Biol. 211, 147160 (1990).
64. Brown, B. A., Lowenhaupt, K., Wilbert, C. M., Hanlon,
C. B. & Rich, A. The Za domain of the editing enzyme
dsRNA adenosine deaminase binds left-handed Z-RNA
as well as Z-DNA. Proc. Natl Acad. Sci. USA 97,
1353213586 (2000).
Online links
DATABASES
The following terms in this article are linked online to:
Entrez: http://www.ncbi.nlm.nih.gov/entrez
DLM1 | E3L | zuotin
LocusLink: http://www.ncbi.nlm.nih.gov/LocusLink
C-MYC | CSF1
OMIM: http://www.ncbi.nlm.nih.gov/Omim
systemic lupus erythematosus
FURTHER INFORMATION
Shuguang Zhangs laboratory: http://web.mit.edu/lms/www
Access to this interactive links box is free online.
www.nature.com/reviews/genetics
ONLINE
Shuguang Zhang is an Associate Director of the Center for Biomedical
Engineering at the Massachusetts Institute of Technology (MIT). He
received his Ph.D. in biochemistry and molecular biology from the
University of California at Santa Barbara, and was an American Cancer
Society Fellow with Alexander Rich at MIT. He discovered a self-assembling peptide system from yeast zuotin whilst studying left-handed ZDNA. This discovery was selected as one of the 15 outstanding research
achievements at MIT over the last quarter of a century. It led him to
actively pursue various self-assembling peptide systems in the design of
biological materials, including peptide nanofiber scaffolds for tissue
engineering, biological surface engineering, molecular switches and surfactant peptide nanotubes.
Alexander Rich is the William Thompson Sedgwick Professor of
Biophysics at the Massachusetts Institute of Technology in Cambridge,
Massachusetts. He was educated at Harvard College, specializing in biochemical sciences, and received an M.D. from Harvard Medical School
in 1949. He has worked at the Massachusetts Institute of Technology
since 1958, and his laboratory focuses on the three-dimensional structure and biological functions of nucleic acids. He is the author of more
than 500 scientific papers, has been a member of the National Academy
of Sciences since 1970, and is the recipient of many awards including the
United States National Medal of Science and the Lomonosov Large Gold
Medal of the Russian Academy of Sciences.
Entrez
E3L
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pro
tein&list_uids=885758&dopt=GenPept
DLM1
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pro
tein&list_uids=25453359&dopt=GenPept
zuotin
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pro
tein&list_uids=418611&dopt=GenPept
LocusLink
C-MYC
http://www.ncbi.nlm.nih.gov/LocusLink/LocRpt.cgi?l=4609
CSF1
http://www.ncbi.nlm.nih.gov/LocusLink/LocRpt.cgi?l=1435
OMIM
systemic lupus erythematosus
http://www.ncbi.nlm.nih.gov/htbin-post/Omim/dispmim?152700
Shuguang Zhangs laboratory
http://web.mit.edu/lms/www